SCL: From the origin of hematopoiesis to stem cells and leukemia

Experimental Hematology

Volumn 32, Issue 1, 2004, Pages 11-24

  Lécuyer, Eric ^a,b   Hoang, Trang ^a,b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HELIX LOOP HELIX PROTEIN; PROTEIN SCL; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CELL ACTIVATION; CELL LINEAGE; CHROMATIN; CHROMOSOME TRANSLOCATION; GENE ACTIVATION; GENE EXPRESSION; GENE LOCUS; GENE SWITCHING; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 6044275816     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2003.10.010     Document Type: Review

References (206)

1. Shivdasani R.A., Orkin S.H. The transcriptional control of hematopoiesis. [see comments] Blood. 87:1996;4025-4039.
2. Tenen D.G., Hromas R., Licht J.D., Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood. 90:1997;489-519.
3. Enver T., Greaves M. Loops, lineage, and leukemia. Cell. 94:1998;9-12.
4. Orkin S.H. Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet. 1:2000;57-64.
5. Sieweke M.H., Graf T. A transcription factor party during blood cell differentiation. Curr Opin Genet Dev. 8:1998;545-551.
6. Rabbitts T.H. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev. 12:1998;2651-2657.
7. Morrison S.J., Uchida N., Weissman I.L. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol. 11:1995;35-71.
8. Rabbitts T.H. Chromosomal translocations in human cancer. Nature. 372:1994;143-149.
9. Look A.T. Oncogenic transcription factors in the human acute leukemias. Science. 278:1997;1059-1064.
10. Murre C. Intertwining proteins in thymocyte development and cancer. Nat Immunol. 1:2000;97-98.
11. Tenen D.G. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 3:2003;89-101.
12. Robb L., Lyons I., Li R., et al. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. Proc Natl Acad Sci U S A. 92:1995;7075-7079.
13. Shivdasani R.A., Mayer E.L., Orkin S.H. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature. 373:1995;432-434.
14. Porcher C., Swat W., Rockwell K., Fujiwara Y., Alt F.W., Orkin S.H. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:1996;47-57.
15. Robb L., Elwood N.J., Elefanty A.G., et al. The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 15:1996;4123-4129.
16. Hall M.A., Curtis D.J., Metcalf D., et al. The critical regulator of embryonic hematopoiesis, SCL, is vital in the adult for megakaryopoiesis, erythropoiesis, and lineage choice in CFU-S12. Proc Natl Acad Sci U S A. 100:2003;992-997.
17. Mikkola H.K., Klintman J., Yang H., et al. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 gene. Nature. 421:2003;547-551.
18. Begley C.G., Green A.R. The SCL gene: from case report to critical hematopoietic regulator. Blood. 93:1999;2760-2770.
19. Massari M.E., Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol. 20:2000;429-440.
20. Ellenberger T., Fass D., Arnaud M., Harrison S.C. Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer. Genes Dev. 8:1994;970-980.
21. Ma P.C., Rould M.A., Weintraub H., Pabo C.O. Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation. Cell. 77:1994;451-459.
22. Ferre-D'Amare A.R., Prendergast G.C., Ziff E.B., Burley S.K. Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain. Nature. 363:1993;38-45.
23. Hsu H.L., Huang L., Tsan J.T., et al. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins. Mol Cell Biol. 14:1994;1256-1265.
24. Hsu H.L., Cheng J.T., Chen Q., Baer R. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol Cell Biol. 11:1991;3037-3042.
25. Begley C.G., Aplan P.D., Davey M.P., et al. Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor δ-chain diversity region and results in a previously unreported fusion transcript. Proc Natl Acad Sci U S A. 86:1989;2031-2035.
26. Begley C.G., Aplan P.D., Denning S.M., Haynes B.F., Waldmann T.A., Kirsch I.R. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc Natl Acad Sci U S A. 86:1989;10128-10132.
27. Finger L.R., Kagan J., Christopher G., et al. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. Proc Natl Acad Sci U S A. 86:1989;5039-5043.
28. Chen Q., Cheng J.T., Tasi L.H., et al. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 9:1990;415-424.
29. Kallianpur A.R., Jordan J.E., Brandt S.J. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood. 83:1994;1200-1208.
30. Silver L., Palis J. Initiation of murine embryonic erythropoiesis: a spatial analysis. Blood. 89:1997;1154-1164.
31. Labastie M.C., Cortes F., Romeo P.H., Dulac C., Peault B. Molecular identity of hematopoietic precursor cells emerging in the human embryo. Blood. 92:1998;3624-3635.
32. Elefanty A.G., Begley C.G., Hartley L., Papaevangeliou B., Robb L. SCL expression in the mouse embryo detected with a targeted lacZ reporter gene demonstrates its localization to hematopoietic, vascular, and neural tissues. Blood. 94:1999;3754-3763.
33. Palis J., Robertson S., Kennedy M., Wall C., Keller G. Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development. 126:1999;5073-5084.
34. Green A.R., Lints T., Visvader J., Harvey R., Begley C.G. SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain. [published erratum appears in Oncogene 1992 Jul;7(7):1459] Oncogene. 7:1992;653-660.
35. Hwang L.Y., Siegelman M., Davis L., Oppenheimer-Marks N., Baer R. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen. Oncogene. 8:1993;3043-3046.
36. Drake C.J., Brandt S.J., Trusk T.C., Little C.D. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis. Dev Biol. 192:1997;17-30.
37. Drake C.J., Fleming P.A. Vasculogenesis in the day 6.5 to 9.5 mouse embryo. Blood. 95:2000;1671-1679.
38. Gering M., Rodaway A.R., Gottgens B., Patient R.K., Green A.R. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J. 17:1998;4029-4045.
39. Liao E.C., Paw B.H., Oates A.C., Pratt S.J., Postlethwait J.H., Zon L.I. SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. Genes Dev. 12:1998;621-626.
40. Mead P.E., Kelley C.M., Hahn P.S., Piedad O., Zon L.I. SCL specifies hematopoietic mesoderm in Xenopus embryos. Development. 125:1998;2611-2620.
41. Dzierzak E., Medvinsky A. Mouse embryonic hematopoiesis. Trends Genet. 11:1995;359-366.
42. Dzierzak E., Medvinsky A., de Bruijn M. Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo. Immunol Today. 19:1998;228-236.
43. Endoh M., Ogawa M., Orkin S., Nishikawa S. SCL/tal-1-dependent process determines a competence to select the definitive hematopoietic lineage prior to endothelial differentiation. EMBO J. 21:2002;6700-6708.
44. Risau W., Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 11:1995;73-91.
45. Orkin S.H., Zon L.I. Hematopoiesis and stem cells: plasticity vs developmental heterogeneity. Nat Immunol. 3:2002;323-328.
46. Minegishi N., Ohta J., Yamagiwa H., et al. The mouse GATA-2 gene is expressed in the para-aortic splanchnopleura and aorta-gonads and mesonephros region. Blood. 93:1999;4196-4207.
47. Kennedy M., Firpo M., Choi K., et al. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature. 386:1997;488-493.
48. Choi K., Kennedy M., Kazarov A., Papadimitriou J.C., Keller G. A common precursor for hematopoietic and endothelial cells. Development. 125:1998;725-732.
49. Visvader J.E., Fujiwara Y., Orkin S.H. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12:1998;473-479.
50. Orkin S.H., Porcher C., Fujiwara Y., Visvader J., Wang L.C. Intersections between blood cell development and leukemia genes. Cancer Res. 59:1999;1784s-1787s.
51. + cells at a diverging point of endothelial and hemopoietic lineages. Development. 125:1998;1747-1757.
52. Faloon P., Arentson E., Kazarov A., et al. Basic fibroblast growth factor positively regulates hematopoietic development. Development. 127:2000;1931-1941.
53. Robertson S.M., Kennedy M., Shannon J.M., Keller G. A transitional stage in the commitment of mesoderm to hematopoiesis requiring the transcription factor SCL/tal-1. Development. 127:2000;2447-2459.
54. Chung Y.S., Zhang W.J., Arentson E., Kingsley P.D., Palis J., Choi K. Lineage analysis of the hemangioblast as defined by FLK1 and SCL expression. Development. 129:2002;5511-5520.
55. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 376:1995;62-66.
56. Shalaby F., Ho J., Stanford W.L., et al. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell. 89:1997;981-990.
57. Hidaka M., Stanford W.L., Bernstein A. Conditional requirement for the Flk-1 receptor in the in vitro generation of early hematopoietic cells. Proc Natl Acad Sci U S A. 96:1999;7370-7375.
58. -/- embryonic stem cells and embryos. Proc Natl Acad Sci U S A. 96:1999;2159-2164.
59. Ema M., Faloon P., Zhang W.J., et al. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev. 17:2003;380-393.
60. Martin R, Lahlil R, Damert A, et al. SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis. Development. In press.
61. Hopwood N.D., Gurdon J.B. Activation of muscle genes without myogenesis by ectopic expression of MyoD in frog embryo cells. Nature. 347:1990;197-200.
62. Lee J.E., Hollenberg S.M., Snider L., Turner D.L., Lipnick N., Weintraub H. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science. 268:1995;836-844.
63. Ma Q., Kintner C., Anderson D.J. Identification of neurogenin, a vertebrate neuronal determination gene. Cell. 87:1996;43-52.
64. Stainier D.Y., Weinstein B.M., Detrich H.W. III, Zon L.I., Fishman M.C. Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development. 121:1995;3141-3150.
65. Liao W., Bisgrove B.W., Sawyer H., et al. The zebrafish gene cloche acts upstream of a flk-1 homologue to regulate endothelial cell differentiation. Development. 124:1997;381-389.
66. Elefanty A.G., Begley C.G., Metcalf D., Barnett L., Kontgen F., Robb L. Characterization of hematopoietic progenitor cells that express the transcription factor SCL, using a lacZ "knock-in" strategy. Proc Natl Acad Sci U S A. 95:1998;11897-11902.
67. Akashi K., Traver D., Miyamoto T., Weissman I.L. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 404:2000;193-197.
68. Herblot S., Steff A.-M., Hugo P., Aplan P.D., Hoang T. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expression. Nat Immunol. 1:2000;138-144.
69. Herblot S., Aplan P.D., Hoang T. A gradient of E2A activity in B-cell development. Mol Cell Biol. 22:2002;886-900.
70. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., Melton D.A. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science. 298:2002;597-600.
71. Green A.R., Salvaris E., Begley C.G. Erythroid expression of the 'helix-loop-helix' gene, SCL. Oncogene. 6:1991;475-479.
72. Visvader J., Begley C.G., Adams J.M. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene. 6:1991;187-194.
73. Mouthon M.A., Bernard O., Mitjavila M.T., Romeo P.H., Vainchenker W., Mathieu-Mahul D. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood. 81:1993;647-655.
74. Brady G., Billia F., Knox J., et al. Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. [published erratum appears in Curr Biol 1995 Oct 1;5(10):1201] Curr Biol. 5:1995;909-922.
75. Pulford K., Lecointe N., Leroy-Viard K., Jones M., Mathieu-Mahul D., Mason D.Y. Expression of TAL-1 proteins in human tissues. Blood. 85:1995;675-684.
76. Hoang T., Paradis E., Brady G., et al. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation. Blood. 87:1996;102-111.
77. Leroy-Viard K., Vinit M.A., Lecointe N., Mathieu-Mahul D., Romeo P.H. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines. Blood. 84:1994;3819-3827.
78. Gottgens B., McLaughlin F., Bockamp E.O., et al. Transcription of the SCL gene in erythroid and CD34-positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements. Oncogene. 15:1997;2419-2428.
79. Gottgens B., Barton L.M., Gilbert J.G., et al. Analysis of vertebrate SCL loci identifies conserved enhancers. Nat Biotechnol. 18:2000;181-186.
80. Sinclair A.M., Gottgens B., Barton L.M., et al. Distinct 5′ SCL enhancers direct transcription to developing brain, spinal cord, and endothelium: neural expression is mediated by GATA factor binding sites. Dev Biol. 209:1999;128-142.
81. Sanchez M., Gottgens B., Sinclair A.M., et al. An SCL 3′ enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors. Development. 126:1999;3891-3904.
82. -/- mice by expressing Scl under the control of a stem cell enhancer. Development. 128:2001;4815-4827.
83. Aplan P.D., Nakahara K., Orkin S.H., Kirsch I.R. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J. 11:1992;4073-4081.
84. Tanigawa T., Nicola N., McArthur G.A., Strasser A., Begley C.G. Differential regulation of macrophage differentiation in response to leukemia inhibitory factor/oncostatin-M/interleukin-6: the effect of enforced expression of the SCL transcription factor. Blood. 85:1995;379-390.
85. + cells: consequence of enforced expression of SCL. Blood. 91:1998;3756-3765.
86. Condorelli G.L., Tocci A., Botta R., et al. Ectopic TAL-1/SCL expression in phenotypically normal or leukemic myeloid precursors: proliferative and antiapoptotic effects coupled with a differentiation blockade. Mol Cell Biol. 17:1997;2954-2969.
87. Valtieri M., Tocci A., Gabbianelli M., et al. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program. Cancer Res. 58:1998;562-569.
88. Mellentin J.D., Smith S.D., Cleary M.L. lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell. 58:1989;77-83.
89. Niwa H., Burdon T., Chambers I., Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12:1998;2048-2060.
90. Matsuda T., Nakamura T., Nakao K., et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18:1999;4261-4269.
91. Lessard J., Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature. 423:2003;255-260.
92. Park I.K., Qian D., Kiel M., et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 423:2003;302-305.
93. Sauvageau G., Thorsteinsdottir U., Eaves C.J., et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9:1995;1753-1765.
94. Antonchuk J., Sauvageau G., Humphries R.K. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell. 109:2002;39-45.
95. Russell E.S. Hereditary anemias of the mouse: a review for geneticists. Adv Genet. 20:1979;357-459.
96. Krosl G., He G., Lefrancois M., et al. Transcription factor SCL is required for c-kit expression and c-Kit function in hemopoietic cells. J Exp Med. 188:1998;439-450.
97. Lecuyer E., Herblot S., Saint-Denis M., et al. The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood. 100:2002;2430-2440.
98. Hemesath T.J., Price E.R., Takemoto C., Badalian T., Fisher D.E. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature. 391:1998;298-301.
99. Goldfarb A.N., Goueli S., Mickelson D., Greenberg J.M. T-cell acute lymphoblastic leukemia - the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein. Blood. 80:1992;2858-2866.
100. Cheng J.T., Hsu H.L., Hwang L.Y., Baer R. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene. 8:1993;677-683.
101. Cheng J.T., Cobb M.H., Baer R. Phosphorylation of the TAL1 oncoprotein by the extracellular-signal-regulated protein kinase ERK1. Mol Cell Biol. 13:1993;801-808.
102. Prasad K.S., Jordan J.E., Koury M.J., Bondurant M.C., Brandt S.J. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products. J Biol Chem. 270:1995;11603-11611.
103. Prasad K.S., Brandt S.J. Target-dependent effect of phosphorylation on the DNA binding activity of the TAL1/SCL oncoprotein. J Biol Chem. 272:1997;11457-11462.
104. Tang T., Prasad K.S., Koury M.J., Brandt S.J. Mitogen-activated protein kinase mediates erythropoietin-induced phosphorylation of the TAL1/SCL transcription factor in murine proerythroblasts. Biochem J. 343 Pt 3:1999;615-620.
105. Tang T., Arbiser J.L., Brandt S.J. Phosphorylation by mitogen-activated protein kinase mediates the hypoxia-induced turnover of the TAL1/SCL transcription factor in endothelial cells. J Biol Chem. 277:2002;18365-18372.
106. Sanchez-Garcia I., Rabbitts T.H. Transcriptional activation by TAL1 and FUS-CHOP proteins expressed in acute malignancies as a result of chromosomal abnormalities. Proc Natl Acad Sci U S A. 91:1994;7869-7873.
107. Wadman I.A., Hsu H.L., Cobb M.H., Baer R. The MAP kinase phosphorylation site of TAL1 occurs within a transcriptional activation domain. Oncogene. 9:1994;3713-3716.
108. Mahajan M.A., Park S.T., Sun X.H. Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins. Oncogene. 12:1996;2343-2350.
109. Zhao X.F., Aplan P.D. SCL binds the human homologue of DRG in vivo. Biochim Biophys Acta. 1448:1998;109-114.
110. Calkhoven C.F., Muller C., Martin R., Krosl G., Hoang T., Leutz A. Translational control of SCL-isoform expression in hematopoietic lineage choice. Genes Dev. 17:2003;959-964.
111. Aplan P.D., Lombardi D.P., Ginsberg A.M., Cossman J., Bertness V.L., Kirsch I.R. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science. 250:1990;1426-1429.
112. Bernard O., Guglielmi P., Jonveaux P., et al. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. Genes Chromosomes Cancer. 1:1990;194-208.
113. Brown L., Cheng J.T., Chen Q., et al. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. EMBO J. 9:1990;3343-3351.
114. Chen Q., Yang C.Y., Tsan J.T., et al. Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. J Exp Med. 172:1990;1403-1408.
115. Bernard O., Lecointe N., Jonveaux P., et al. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene. 6:1991;1477-1488.
116. Aplan P.D., Lombardi D.P., Reaman G.H., Sather H.N., Hammond G.D., Kirsch I.R. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia. Blood. 79:1992;1327-1333.
117. Bash R.O., Crist W.M., Shuster J.J., et al. Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood. 81:1993;2110-2117.
118. Bash R.O., Hall S., Timmons C.F., et al. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group study. Blood. 86:1995;666-676.
119. Ferrando A.A., Neuberg D.S., Staunton J., et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 1:2002;75-87.
120. Robb L., Rasko J.E., Bath M.L., Strasser A., Begley C.G. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene. 10:1995;205-209.
121. Larson R.C., Lavenir I., Larson T.A., et al. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 15:1996;1021-1027.
122. Condorelli G.L., Facchiano F., Valtieri M., et al. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res. 56:1996;5113-5119.
123. Kelliher M.A., Seldin D.C., Leder P. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIα EMBO J. 15:1996;5160-5166.
124. Elwood N.J., Cook W.D., Metcalf D., Begley C.G. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line. Oncogene. 8:1993;3093-3101.
125. Aplan P.D., Jones C.A., Chervinsky D.S., et al. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO J. 16:1997;2408-2419.
126. Curtis D.J., Robb L., Strasser A., Begley C.G. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice. Oncogene. 15:1997;2975-2983.
127. Chervinsky D.S., Zhao X.F., Lam D.H., Ellsworth M., Gross K.W., Aplan P.D. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice. Mol Cell Biol. 19:1999;5025-5035.
128. O'Neil J., Billa M., Oikemus S., Kelliher M. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice. Oncogene. 20:2001;3897-3905.
129. Valge-Archer V.E., Osada H., Warren A.J., et al. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci U S A. 91:1994;8617-8621.
130. Wadman I., Li J., Bash R.O., et al. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J. 13:1994;4831-4839.
131. Dawid I.B., Breen J.J., Toyama R. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet. 14:1998;156-162.
132. Dong W.F., Billia F., Atkins H.L., Iscove N.N., Minden M.D. Expression of rhombotin 2 in normal and leukaemic haemopoietic cells. Br J Haematol. 93:1996;280-286.
133. Delassus S., Titley I., Enver T. Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo. Blood. 94:1999;1495-1503.
134. Manaia A., Lemarchandel V., Klaine M., et al. Lmo2 and GATA-3 associated expression in intraembryonic hemogenic sites. Development. 127:2000;643-653.
135. Warren A.J., Colledge W.H., Carlton M.B., Evans M.J., Smith A.J., Rabbitts T.H. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell. 78:1994;45-57.
136. Yamada Y., Warren A.J., Dobson C., Forster A., Pannell R., Rabbitts T.H. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci U S A. 95:1998;3890-3895.
137. Yamada Y., Pannell R., Forster A., Rabbitts T.H. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci U S A. 97:2000;320-324.
138. Feuerstein R., Wang X., Song D., Cooke N.E., Liebhaber S.A. The LIM/double zinc-finger motif functions as a protein dimerization domain. Proc Natl Acad Sci U S A. 91:1994;10655-10659.
139. Arber S., Caroni P. Specificity of single LIM motifs in targeting and LIM/LIM interactions in situ. Genes Dev. 10:1996;289-300.
140. Osada H., Grutz G., Axelson H., Forster A., Rabbitts T.H. Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc Natl Acad Sci U S A. 92:1995;9585-9589.
141. Agulnick A.D., Taira M., Breen J.J., Tanaka T., Dawid I.B., Westphal H. Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature. 384:1996;270-272.
142. Jurata L.W., Kenny D.A., Gill G.N. Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc Natl Acad Sci U S A. 93:1996;11693-11698.
143. Ono Y., Fukuhara N., Yoshie O. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL. J Biol Chem. 272:1997;4576-4581.
144. Bach I., Carriere C., Ostendorff H.P., Andersen B., Rosenfeld M.G. A family of LIM domain-associated cofactors confer transcriptional synergism between LIM and Otx homeodomain proteins. Genes Dev. 11:1997;1370-1380.
145. Visvader J.E., Mao X., Fujiwara Y., Hahm K., Orkin S.H. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proc Natl Acad Sci U S A. 94:1997;13707-13712.
146. Wadman I.A., Osada H., Grutz G.G., et al. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 16:1997;3145-3157.
147. Valge-Archer V., Forster A., Rabbitts T.H. The LMO1 AND LDB1 proteins interact in human T cell acute leukaemia with the chromosomal translocation t(11;14)(p15;q11). Oncogene. 17:1998;3199-3202.
148. Grutz G.G., Bucher K., Lavenir I., Larson T., Larson R., Rabbitts T.H. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J. 17:1998;4594-4605.
149. Ono Y., Fukuhara N., Yoshie O. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol Cell Biol. 18:1998;6939-6950.
150. Engel I., Murre C. The function of E- and Id proteins in lymphocyte development. Nat Rev Immunol. 1:2001;193-199.
151. Goardon N., Schuh A., Hajar I., et al. Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation. Blood. 100:2002;491-500.
152. Murre C., McCaw P.S., Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell. 56:1989;777-783.
153. Hu J.S., Olson E.N., Kingston R.E. HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol Cell Biol. 12:1992;1031-1042.
154. Roberts V.J., Steenbergen R., Murre C. Localization of E2A mRNA expression in developing and adult rat tissues. Proc Natl Acad Sci U S A. 90:1993;7583-7587.
155. Bain G., Maandag E.C., Izon D.J., et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell. 79:1994;885-892.
156. Zhuang Y., Soriano P., Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell. 79:1994;875-884.
157. Zhuang Y., Cheng P., Weintraub H. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol Cell Biol. 16:1996;2898-2905.
158. Bain G., Robanus Maandag E.C., te Riele H.P., et al. Both E12 and E47 allow commitment to the B cell lineage. Immunity. 6:1997;145-154.
159. Bain G., Engel I., Robanus Maandag E.C., et al. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol. 17:1997;4782-4791.
160. Yan W., Young A.Z., Soares V.C., Kelley R., Benezra R., Zhuang Y. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol Cell Biol. 17:1997;7317-7327.
161. Murre C. Role of helix-loop-helix proteins in lymphocyte development. Cold Spring Harb Symp Quant Biol. 64:1999;39-44.
162. Fisch P., Boehm T., Lavenir I., et al. T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. Oncogene. 7:1992;2389-2397.
163. McGuire E.A., Rintoul C.E., Sclar G.M., Korsmeyer S.J. Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma. Mol Cell Biol. 12:1992;4186-4196.
164. Larson R.C., Fisch P., Larson T.A., et al. T cell tumours of disparate phenotype in mice transgenic for Rbtn-2. Oncogene. 9:1994;3675-3681.
165. Larson R.C., Osada H., Larson T.A., Lavenir I., Rabbitts T.H. The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. Oncogene. 11:1995;853-862.
166. - lymphocytes in the thymus and T-cell tumors in transgenic mice. Blood. 86:1995;3060-3071.
167. Blom B., Heemskerk M.H., Verschuren M.C., et al. Disruption of α β but not of γ δ T cell development by overexpression of the helix-loop-helix protein Id3 in committed T cell progenitors. EMBO J. 18:1999;2793-2802.
168. Tremblay M., Herblot S., Lecuyer E., Hoang T. Regulation of pTα gene expression by a dosage of E2A, HEB, and SCL. J Biol Chem. 278:2003;12680-12687.
169. Bernard M., Delabesse E., Novault S., Hermine O., Macintyre E.A. Antiapoptotic effect of ectopic TAL1/SCL expression in a human leukemic T-cell line. Cancer Res. 58:1998;2680-2687.
170. Park S.T., Nolan G.P., Sun X.H. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells. J Exp Med. 189:1999;501-508.
171. Doyle K., Zhang Y., Baer R., Bina M. Distinguishable patterns of protein-DNA interactions involving complexes of basic helix-loop-helix proteins. J Biol Chem. 269:1994;12099-12105.
172. Hsu H.L., Wadman I., Tsan J.T., Baer R. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc Natl Acad Sci U S A. 91:1994;5947-5951.
173. Voronova A.F., Lee F. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc Natl Acad Sci U S A. 91:1994;5952-5956.
174. Bernard M., Delabesse E., Smit L., et al. Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRαδ enhancers. Int Immunol. 10:1998;1539-1549.
175. Park S.T., Sun X.H. The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition. J Biol Chem. 273:1998;7030-7037.
176. Barndt R.J., Dai M., Zhuang Y. Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB. Mol Cell Biol. 20:2000;6677-6685.
177. Benezra R., Davis R.L., Lockshon D., Turner D.L., Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell. 61:1990;49-59.
178. Massari M.E., Grant P.A., Pray-Grant M.G., Berger S.L., Workman J.L., Murre C. A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol Cell. 4:1999;63-73.
179. Bradney C., Hjelmeland M., Komatsu Y., Yoshida M., Yao T.P., Zhuang Y. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J Biol Chem. 278:2003;2370-2376.
180. Xia Y., Brown L., Yang C.Y., et al. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. Proc Natl Acad Sci U S A. 88:1991;11416-11420.
181. Wang J., Jani-Sait S.N., Escalon E.A., et al. The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene. Proc Natl Acad Sci U S A. 97:2000;3497-3502.
182. Hartwell L.H., Hopfield J.J., Leibler S., Murray A.W. From molecular to modular cell biology. Nature. 402:1999;C47-C52.
183. Vitelli L., Condorelli G., Lulli V., et al. A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts. Mol Cell Biol. 20:2000;5330-5342.
184. Tsai F.Y., Keller G., Kuo F.C., et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 371:1994;221-226.
185. Tsai F.Y., Orkin S.H. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood. 89:1997;3636-3643.
186. Weiss M.J., Keller G., Orkin S.H. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev. 8:1994;1184-1197.
187. Fujiwara Y., Browne C.P., Cunniff K., Goff S.C., Orkin S.H. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci U S A. 93:1996;12355-12358.
188. Shivdasani R.A., Fujiwara Y., McDevitt M.A., Orkin S.H. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16:1997;3965-3973.
189. Chang A.N., Cantor A.B., Fujiwara Y., et al. GATA-factor dependence of the multitype zinc-finger protein FOG-1 for its essential role in megakaryopoiesis. Proc Natl Acad Sci U S A. 99:2002;9237-9242.
190. Porcher C., Liao E.C., Fujiwara Y., Zon L.I., Orkin S.H. Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development. 126:1999;4603-4615.
191. Vyas P., McDevitt M.A., Cantor A.B., Katz S.G., Fujiwara Y., Orkin S.H. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development. 126:1999;2799-2811.
192. Anderson K.P., Crable S.C., Lingrel J.B. Multiple proteins binding to a GATA-E box-GATA motif regulate the erythroid Kruppel-like factor (EKLF) gene. J Biol Chem. 273:1998;14347-14354.
193. Kappel A., Ronicke V., Damert A., Flamme I., Risau W., Breier G. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood. 93:1999;4284-4292.
194. Anderson K.P., Crable S.C., Lingrel J.B. The GATA-E box-GATA motif in the EKLF promoter is required for in vivo expression. Blood. 95:2000;1652-1655.
195. Kappel A., Schlaeger T.M., Flamme I., Orkin S.H., Risau W., Breier G. Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development. Blood. 96:2000;3078-3085.
196. Cohen-Kaminsky S., Maouche-Chretien L., Vitelli L., et al. Chromatin immunoselection defines a TAL-1 target gene. EMBO J. 17:1998;5151-5160.
197. Morcillo P., Rosen C., Baylies M.K., Dorsett D. Chip, a widely expressed chromosomal protein required for segmentation and activity of a remote wing margin enhancer in Drosophila. Genes Dev. 11:1997;2729-2740.
198. Fernandez-Funez P., Lu C.H., Rincon-Limas D.E., Garcia-Bellido A., Botas J. The relative expression amounts of apterous and its co-factor dLdb/Chip are critical for dorso-ventral compartmentalization in the Drosophila wing. EMBO J. 17:1998;6846-6853.
199. Mukhopadhyay M., Teufel A., Yamashita T., et al. Functional ablation of the mouse Ldb1 gene results in severe patterning defects during gastrulation. Development. 130:2003;495-505.
200. Ramain P., Khechumian R., Khechumian K., Arbogast N., Ackermann C., Heitzler P. Interactions between chip and the achaete/scute-daughterless heterodimers are required for pannier-driven proneural patterning. Mol Cell. 6:2000;781-790.
201. Heitzler P., Vanolst L., Biryukova I., Ramain P. Enhancer-promoter communication mediated by Chip during Pannier-driven proneural patterning is regulated by Osa. Genes Dev. 17:2003;591-596.
202. Huang S., Qiu Y., Stein R.W., Brandt S.J. p300 functions as a transcriptional coactivator for the TAL1/SCL oncoprotein. Oncogene. 18:1999;4958-4967.
203. Huang S., Brandt S.J. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol Cell Biol. 20:2000;2248-2259.
204. Huang S., Qiu Y., Shi Y., Xu Z., Brandt S.J. P/CAF-mediated acetylation regulates the function of the basic helix-loop-helix transcription factor TAL1/SCL. EMBO J. 19:2000;6792-6803.
205. Cavalli G., Paro R. Epigenetic inheritance of active chromatin after removal of the main transactivator. Science. 286:1999;955-958.
206. Cosma M.P., Tanaka T., Nasmyth K. Ordered recruitment of transcription and chromatin remodeling factors to a cell cycle- and developmentally regulated promoter. Cell. 97:1999;299-311.